Clinical Trials Browser

Phase 1 × Neoplasms × Nebulizers and Vaporizers × Clear all

NCT03326752 2020-06-17

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Phase 1 Completed

Lung Neoplasms, Neoplasms